Rocket Lab stock rises nearly 7% as new launch contracts boost buying momentum

Traders Union
All News
Stocks
Rocket lab surges 6.8% today to $75.28

Highlights

Shares of Rocket Lab rose after it secured a 20-mission Electron launch agreement with Synspective, bringing the client's total to 47 contracted launches.
Rocket Lab's backlog now exceeds 100 missions, driven by a $266 million U.S. Space Force contract and a separate satellite bus agreement with Viasat.
Rocket Lab stock advanced 6.8% to $75.28 with intraday volatility of 3.96%, and is expected to range between $69.32 and $77.79 over the next five sessions amid mixed technical signals.

Mission backlog expands as government and commercial deals fuel gains

Rocket Lab shares have surged following the announcement of a major Electron launch agreement with Synspective, covering 20 new missions from 2028 to 2031 and raising its total Electron contracts with this client to 47. The backlog now exceeds 100 missions, driven further by a record $266 million multi-launch contract with the U.S. Space Force for at least 12 suborbital launches and a separate agreement to build a GEO satellite bus for Viasat. Recent successful Electron missions contributed to multiple sessions of gains and highlight the company's momentum in both government and commercial contracts.

Anton Kharitonov, expert at Traders Union, remains cautious despite the recent surge in Rocket Lab shares. He sees short-term optimism driven by news, but notes the price is still below the long-term 200-day moving average. He stresses the risk of overbought conditions and mixed technical signals. Backlog growth is promising but does not offset weak long-term momentum and high volatility. "Traders should stay defensive while Rocket Lab fails to reclaim $81.32 — news hype fades fast if technical resistance holds."

Viktoras Karapetjanc, expert at Traders Union, highlights Rocket Lab’s expanding commercial backlog and its strategic partnerships. He believes recent deals with Synspective and the U.S. Space Force reinforce long-term demand and underpin further growth potential. Karapetjanc notes positive investor sentiment and a robust contract pipeline. "With momentum from new agreements, the bullish structure remains intact, and further upside toward $77.79 is likely in this growth phase."

Jainam Mehta, market strategist, observes positive short- and medium-term trends as Rocket Lab trades above its 20- and 50-day moving averages. He cautions that the price remains capped by the 200-day average, indicating long-term caution. Mixed oscillators suggest tactical opportunities for range-based trades. "A potential breakout above $77.79 would shift bias upward, but traders should be alert for false signals if volatility persists."

Mixed momentum as short-term strength faces long-term resistance

Rocket Lab is trading above both its 20-day and 50-day moving averages at $67.28 and $69.68, respectively, but remains below its 200-day moving average at $81.32. This setup signals positive momentum in the short and medium term, while the long-term trend remains bearish. Support is noted near $74.48 and resistance at $77.79. Momentum indicators are mixed: the MACD shows a bullish bias, ADX is neutral, the RSI, CCI, and Awesome Oscillator all tilt positive, while the Stochastic RSI is neutral. Bull/Bear Power reflects buyers dominating intraday momentum, indicating overbought conditions. The last price of $75.28 is near session highs, with intraday volatility at 3.96%. Oscillators are not yet fully aligned.

Earlier, analysts noted that Rocket Lab was exhibiting short- and medium-term bullish momentum, though tempered by persistent long-term resistance. The latest contract wins and surge above short-term averages expand on this outlook, with a sustained move beyond $77.79 now serving as the key technical threshold for confirming a breakout.

Source of Data: RKLB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.